Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
miR-122 regulates hepatic lipid metabolism and tumor suppression
Jessica Wen, Joshua R. Friedman
Jessica Wen, Joshua R. Friedman
Published August 1, 2012; First published July 23, 2012
Citation Information: J Clin Invest. 2012;122(8):2773-2776. https://doi.org/10.1172/JCI63966.
View: Text | PDF
Category: Commentary

miR-122 regulates hepatic lipid metabolism and tumor suppression

  • Text
  • PDF
Abstract

In this issue of JCI, two independent groups describe the effects of germline and liver-specific deletion of Mir122a, the predominant liver miRNA. Their findings reveal a critical role for miR-122 in fat and cholesterol metabolism but suggest that other metabolic actions of the liver are independent of miR-122. Knockout mice also displayed hepatic inflammation, fibrosis, and a high incidence of hepatocellular carcinoma, suggesting that miR-122 has a tumor suppressor role in hepatocytes.

Authors

Jessica Wen, Joshua R. Friedman

×

Figure 1

Overview of the consequences of miR-122 loss on hepatocyte function.

Options: View larger image (or click on image) Download as PowerPoint
Overview of the consequences of miR-122 loss on hepatocyte function.
The...
The normal functions of the hepatocyte include carbohydrate and lipid metabolism, bilirubin excretion, and detoxification of endogenous compounds and xenobiotics. In this issue, Tsai et al. and Hsu et al. demonstrate that loss of miR-122 results in increased lipid synthesis and decreased lipid export, but other hepatocyte functions are unaltered. Loss of miR-122 also led to increased inflammation and fibrosis, and eventually the development of HCC, suggesting the miR-122 plays a tumor-suppressive role.
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts